FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice

被引:56
|
作者
Yakala, Gopala K. [1 ,2 ]
Cabrera-Fuentes, Hector A. [3 ,4 ,5 ,6 ,7 ]
Crespo-Avilan, Gustavo E. [3 ,4 ]
Rattanasopa, Chutima [1 ,2 ,3 ]
Burlacu, Alexandrina [8 ]
George, Benjamin L. [4 ]
Anand, Kaviya [1 ,2 ]
Mayan, David Castano [1 ,2 ]
Corliano, Maria [1 ,2 ]
Hernandez-Resendiz, Sauri [3 ,4 ]
Wu, Zihao [1 ,2 ]
Schwerk, Anne M. K. [9 ]
Tan, Amberlyn L. J. [1 ,2 ]
Trigueros-Motos, Laia [1 ,2 ]
Chevre, Raphael [1 ,2 ]
Chua, Tricia [1 ,2 ]
Kleemann, Robert [9 ,10 ]
Liehn, Elisa A. [4 ,11 ,12 ]
Hausenloy, Derek J. [2 ,3 ,4 ,13 ,14 ,15 ]
Ghosh, Sujoy [3 ,4 ,16 ]
Singaraja, Roshni R. [1 ,2 ]
机构
[1] A STAR Inst, Translat Labs Genet Med, 8A Biomed Grove, Singapore 138648, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, 8A Biomed Grove, Singapore 138648, Singapore
[3] Duke NUS Med Sch, Cardiovasc & Metab Disorders Program, 8 Coll Rd, Singapore 169857, Singapore
[4] Natl Heart Ctr Singapore, Natl Heart Res Inst, Singapore, Singapore
[5] Justus Liebig Univ, Med Sch, Inst Biochem, Giessen, Germany
[6] Kazan Fed Univ, Dept Microbiol, Kazan, Russia
[7] Tecnol Monterrey, Escuela Ingn & Ciencias, Ctr Biotecnol FEMSA, Nuevo Leon, Mexico
[8] Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania
[9] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands
[10] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands
[11] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, Aachen, Germany
[12] Univ Med, Human Genet Lab, Craiova, Romania
[13] UCL, Hatter Cardiovasc Inst, London, England
[14] Univ Coll London Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England
[15] St Bartholomews Hosp, Barbs Heart Ctr, London, England
[16] North Carolina Cent Univ, Biomed, Biotechnol Res Inst, Durham, NC 27707 USA
基金
英国医学研究理事会;
关键词
atherosclerosis; coronary artery disease; Furin; macrophages; vascular remodeling; GENOME-WIDE ASSOCIATION; PROPROTEIN CONVERTASES; MATRIX METALLOPROTEINASES; PROTECTS; DESIGN; PCSK9; MMP-9; ARTERIOSCLEROSIS; OVEREXPRESSION; DEFINITION;
D O I
10.1161/ATVBAHA.118.311903
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Atherosclerotic coronary artery disease is the leading cause of death worldwide, and current treatment options are insufficient. Using systems-level network cluster analyses on a large coronary artery disease case-control cohort, we previously identified PCSK3 (proprotein convertase subtilisin/kexin family member 3; FURIN) as a member of several coronary artery disease-associated pathways. Thus, our objective is to determine the role of FURIN in atherosclerosis. Approach and Results In vitro, FURIN inhibitor treatment resulted in reduced monocyte migration and reduced macrophage and vascular endothelial cell inflammatory and cytokine gene expression. In vivo, administration of an irreversible inhibitor of FURIN, -1-PDX (1-antitrypsin Portland), to hyperlipidemic Ldlr(-/-) mice resulted in lower atherosclerotic lesion area and a specific reduction in severe lesions. Significantly lower lesional macrophage and collagen area, as well as systemic inflammatory markers, were observed. MMP2 (matrix metallopeptidase 2), an effector of endothelial function and atherosclerotic lesion progression, and a FURIN substrate was significantly reduced in the aorta of inhibitor-treated mice. To determine FURIN's role in vascular endothelial function, we administered -1-PDX to Apoe(-/-) mice harboring a wire injury in the common carotid artery. We observed significantly decreased carotid intimal thickness and lower plaque cellularity, smooth muscle cell, macrophage, and inflammatory marker content, suggesting protection against vascular remodeling. Overexpression of FURIN in this model resulted in a significant 67% increase in intimal plaque thickness, confirming that FURIN levels directly correlate with atherosclerosis. Conclusions We show that systemic inhibition of FURIN in mice decreases vascular remodeling and atherosclerosis. FURIN-mediated modulation of MMP2 activity may contribute to the atheroprotection observed in these mice.
引用
收藏
页码:387 / 401
页数:15
相关论文
共 50 条
  • [1] Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury
    Lei, Xia
    Basu, Debapriya
    Li, Zhiqiang
    Zhang, Maoxiang
    Rudic, R. Dan
    Jiang, Xian-Cheng
    Jin, Weijun
    ATHEROSCLEROSIS, 2014, 236 (01) : 121 - 130
  • [2] Therapeutic Immunization with an Antiglycosaminoglycan Antibody Reduces Atherosclerotic Lesion Progression in Apolipoprotein E-Deficient Mice
    Sarduy, Roger
    Brito, Victor
    Soto, Yosdel
    Delgado-Roche, Livan
    Grinan, Tania
    Viera, Justo
    Gonzalez, Jordan
    Marleau, Sylvie
    Vazquez, Ana M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
  • [3] Late-Stage Captopril Treatment Reduces Atherosclerotic Lesion Progression in Apolipoprotein E Knockout Mice
    Procknow, Jesse David
    Sprague, Randy
    Stephenson, Alan H.
    FASEB JOURNAL, 2009, 23
  • [4] Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition
    Flach, Rachel J. Roth
    Su, Chunyan
    Bollinger, Eliza
    Cortes, Christian
    Robertson, Andrew W.
    Opsahl, Alan C.
    Coskran, Timothy M.
    Maresca, Kevin P.
    Keliher, Edmund J.
    Yates, Phillip D.
    Kim, Albert M.
    Kalgutkar, Amit S.
    Buckbinder, Leonard
    PLOS ONE, 2019, 14 (03):
  • [5] The effect of lacidipine on atherosclerotic lesion progression in apoE knockout mice
    Cristofori, P
    Lanzoni, A
    Spagnolo, D
    Cominacini, L
    Pastorino, A
    Quartaroli, M
    Gaviraghi, G
    Trist, DG
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 33 - 33
  • [6] Altered vascular remodeling in osteopontin-deficient atherosclerotic mice
    Ström, Å
    Franzén, A
    Wängnerud, C
    Knutsson, AK
    Heinegärd, D
    Hultgårdh-Nilsson, A
    JOURNAL OF VASCULAR RESEARCH, 2004, 41 (04) : 314 - 322
  • [7] Inhibition of Pro-inflammatory Cytokine Light Reduces Atherosclerotic Lesion Development in Apo E-/- Mice
    Akhavanpoor, Mohammad
    Erbel, Christian
    Shankar, Vijay
    Celik, Sultan
    Lasitschka, Felix
    Katus, Hugo A.
    Dengler, Thomas J.
    CIRCULATION, 2009, 120 (18) : S1065 - S1065
  • [8] Troglitazone reduces the atherosclerotic lesion of apolipoprotein E-deficient mice
    Miyata, M
    Biro, S
    Orihara, K
    Eto, H
    Tei, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 251A - 251A
  • [9] CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice
    Boulaftali, Yacine
    Owens, A. Phillip, III
    Beale, Ashley
    Piatt, Raymond
    Casari, Caterina
    Lee, Robert H.
    Conley, Pamela B.
    Paul, David S.
    Mackman, Nigel
    Bergmeier, Wolfgang
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (05) : 792 - 799
  • [10] Inhibition of GSDMD activation by Z-LLSD-FMK or Z-YVAD-FMK reduces vascular inflammation and atherosclerotic lesion development in ApoE-/- mice
    Zhang, Bao-Li
    Yu, Peng
    Su, En-Yong
    Zhang, Chun-Yu
    Xie, Shi-Yao
    Yang, Xue
    Zou, Yun-Zeng
    Liu, Ming
    Jiang, Hong
    FRONTIERS IN PHARMACOLOGY, 2023, 14